About

WearLinq is an innovative healthcare technology company delivering next-generation cardiac monitoring solutions through its FDA-cleared, 6-lead wearable ECG device, the eWave. Leveraging advanced AI algorithms, WearLinq provides cardiologists with real-time, multidimensional heart data and automates the analysis and reporting of cardiac events, leading to highly accurate, expedited diagnostics and actionable insights. By seamlessly integrating AI-powered analytics, continuous wireless monitoring, and patient-centric mobile connectivity, WearLinq is transforming cardiac care—enabling faster, more precise diagnoses while improving both patient experience and clinical outcomes.